MedTrace Logo

Long-term Review of a Cohort of Arthroscopic Bankart Interventions

NCT03654118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2018-08-31

No results posted yet for this study

Summary

Recurrent instability is the most common chronic shoulder pathology of the young and athletic patient. It is a source of functional, sporting and professional disability, and a permanent apprehension to the use of the affected shoulder.

Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet).

Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious.

Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention.

The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications.

The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability

Conditions

  • Recurrent Anterior Shoulder Instability

Interventions

OTHER

Phone follow-up

Through a short phone interview : * Determination of a complication (Infection, capsulitis, recurrence) * Determination of the Rowe score * Determination of the Walch-Duplay score

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Hervé THOMAZEAU, MD, PhD · Rennes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2017-11-09
Completion
2017-11-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03654118 on ClinicalTrials.gov